Luqa Pharmaceuticals has launched its initial product in China, Strataderm® Gel, an innovative silicone gel scar treatment that has been approved by the SFDA. Strataderm is a rapidly drying topical formulation that helps prevent excessive scarring following surgery. Founded in 2010, Luqa is a private company, backed by healthcare focused European private investors. It is headquartered in Hong Kong with an office in Shanghai and a focus on the China market. More details.... Share this with colleagues: // //